Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHRS | PRE | ARTV | ||
| Company | Coherus Oncology Inc | Prenetics Global Limited Class A Ordinary Share | Artiva Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8900 | 16.29 | 11.68 | ||
| High | 2.1100 | 17.84 | 11.68 | ||
| Low | 1.8700 | 16.28 | 10.43 | ||
| Latest | 1.9500 | 17.55 | 10.60 | ||
| Change | +0.2000 | +1.39 | -0.29 | ||
| % Change | +11.43% | +8.60% | -2.66% | ||
| Volume | 3,707,700 | 226,500 | 864,100 | ||
| 20-Day Average Volume | 1,145,160 | 178,810 | 651,170 | ||
| Previous Close | 1.7500 | 16.16 | 10.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8168 | 17.47 | 10.92 | ||
| 20-Day Raw Stochastic | 62.35% | 48.44% | 47.11% | ||
| 20-Day Relative Strength | 58.11 | 48.26 | 55.61 | ||
| Weighted Alpha | +112.22 | +86.03 | +29.22 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.72% since 05/04/26 | +6.36% since 05/04/26 | -6.11% since 05/04/26 | ||
| Low | 1.7100 on 05/07/26 | 15.06 on 05/07/26 | 10.20 on 05/08/26 | ||
| High | 2.1100 on 05/11/26 | 17.84 on 05/11/26 | 13.00 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +16.07% since 04/10/26 | -1.02% since 04/10/26 | +55.65% since 04/10/26 | ||
| Low | 1.6200 on 04/13/26 | 15.06 on 05/07/26 | 6.74 on 04/13/26 | ||
| High | 2.1100 on 05/11/26 | 20.20 on 04/27/26 | 14.53 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | -4.41% since 02/11/26 | -17.99% since 02/11/26 | +175.32% since 02/11/26 | ||
| Low | 1.5200 on 03/20/26 | 14.55 on 03/05/26 | 3.73 on 02/12/26 | ||
| High | 2.1100 on 05/11/26 | 23.63 on 03/25/26 | 14.53 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +44.44% since 11/11/25 | +35.73% since 11/11/25 | +195.26% since 11/11/25 | ||
| Low | 1.0900 on 11/21/25 | 11.36 on 11/18/25 | 2.96 on 12/09/25 | ||
| High | 2.6158 on 01/27/26 | 23.63 on 03/25/26 | 14.53 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 269,882 | 271,940 | 269,168 | ||
| Shares Outstanding, K | 154,218 | 16,828 | 24,717 | ||
| Annual Sales | 42,170,000 | 92,390,000 | 0 | ||
| Annual Net Income | 168,020,000 | -37,710,000 | -83,870,000 | ||
| Last Quarter Sales | 12,750,000 | 33,840,000 | 0 | ||
| Last Quarter Net Income | -37,640,000 | -7,500,000 | -20,770,000 | ||
| 60-Month Beta | 1.01 | 0.15 | 2.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 03/09/26 | -0.27 on 02/18/26 | -0.84 on 03/10/26 | ||
| Earnings Date | 05/11/26 | 06/11/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/17/16 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||